Switching from serum to plasma: Implementation of BD Vacutainer® Barricor™ Plasma Blood Collection Tubes improves sample quality and laboratory turnaround time.

Switching from serum to plasma: Implementation of BD Vacutainer® Barricor™ Plasma Blood Collection Tubes improves sample quality and laboratory turnaround time.

For blood, most standard 24/7 (immuno) chemical parameters measured either in serum or lithium-heparin plasma. Standard tube gel serum and plasma have their flaws when timely analysis required high quality results.

Serum require the freezing time and disruption of bubbles in the plasma gel and hydrophobic analyte adsorption into the gel layer is potentially harmful high-quality results from gel lithium heparin tube.

We sought to evaluate the impact of the BD Vacutainer® Barricor ™ Tube (Barricor ™) in laboratory efficiency by measuring its effect on TAT and quality of the samples, as well as evaluating opportunities potential costs resulting from an increase in the sample data extracted quality.

TAT and remediation activities and was arrested for two 6 phases of the moon. Serum is used as the dominant matrix of the first stage and Barricor ™ plasma used in the second phase.Barricor ™ significantly reduced the median TAT, especially for routine sample-priority during peak hours.

TAT key performance indicators (percentage yield available within 90 minutes) increased to> 90% for STAT and routine priority samples. Conversion of gel serum, Barricor ™ reduces fibrin-related remediation activities from 2.3% to 0.4%. This resulted in a reduction in remediation-related costs of € 6010.47 during the study period.

By apply Barricor ™, we see a significant reduction in TAT and reduction of fibrin-related remediation time and cost, when compared to the dominant serum workflow. TAT improved opens up the possibility of consolidation to a single priority level, eliminating the need to use STAT priority level.

Switching from serum to plasma: Implementation of BD Vacutainer® Barricor™ Plasma Blood Collection Tubes improves sample quality and laboratory turnaround time.
Switching from serum to plasma: Implementation of BD Vacutainer® Barricor™ Plasma Blood Collection Tubes improves sample quality and laboratory turnaround time.

Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples.

For blood, most standard 24/7 (immuno) chemical parameters measured either in serum or lithium-heparin plasma. Standard tube gel serum and plasma have their flaws when timely analysis required high quality results. Serum require the freezing time and disruption of bubbles in the plasma gel and hydrophobic analyte adsorption into the gel layer is potentially harmful high-quality results from gel lithium heparin tube.

We sought to evaluate the impact of the BD Vacutainer® Barricor ™ Tube (Barricor ™) in laboratory efficiency by measuring its effect on TAT and quality of the samples, as well as evaluating opportunities potential costs resulting from an increase in the sample data extracted quality.

TAT and remediation activities and was arrested for two 6 phases of the moon. Serum is used as the dominant matrix of the first stage and Barricor ™ plasma used in the second phase.

Barricor ™ significantly reduced the median TAT, especially for routine sample-priority during peak hours. TAT key performance indicators (percentage yield available within 90 minutes) increased to> 90% for STAT and routine priority samples. Conversion of gel serum, Barricor ™ reduces fibrin-related remediation activities from 2.3% to 0.4%.

This resulted in a reduction in remediation-related costs of € 6010.47 during the study period.By apply Barricor ™, we see a significant reduction in TAT and reduction of fibrin-related remediation time and cost, when compared to the dominant serum workflow. TAT improved opens up the possibility of consolidation to a single priority level, eliminating the need to use STAT priority level.